CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-13 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion · Employee Stock Option (Right to Acquire) | −20,000 | 27,000 | ||
| 2024-02-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion 10b5-1 | +11,000 | $36.75 | $404K | 50,502.69 |
| 2024-02-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −470 | $86.35 | $41K | 50,032.69 |
| 2024-02-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −10,530 | $85.81 | $904K | 39,502.69 |
| 2024-02-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −11,000 | 27,000 | ||
| 2024-02-12 | SELLERS ROBERT W.A. SVP, Corporate Controller | Exercise or conversion | +12,210 | $36.75 | $449K | 25,297.18 |
| 2024-02-12 | SELLERS ROBERT W.A. SVP, Corporate Controller | Sale | −12,210 | $87.00 | $1.1M | 13,087.18 |
| 2024-02-12 | SELLERS ROBERT W.A. SVP, Corporate Controller | Exercise or conversion · Employee Stock Option (Right to Acquire) | −12,210 | 0 | ||
| 2024-02-08 | STONE HEISZ LESLIE Director | Exercise or conversion | +7,056 | $36.86 | $260K | 34,036 |
| 2024-02-08 | STONE HEISZ LESLIE Director | Sale | −7,056 | $86.45 | $610K | 26,980 |
| 2024-02-08 | STONE HEISZ LESLIE Director | Exercise or conversion · Director Stock Option (Right to Acquire) | −7,056 | 0 | ||
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 33,835.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −1,000 | $89.61 | $90K | 32,835.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −6,422 | $88.63 | $569K | 26,413.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −9,761 | $86.44 | $844K | 16,652.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −12,167 | $87.55 | $1.1M | 4,485.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 88,050 | ||
| 2024-02-01 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion 10b5-1 | +7,255 | $36.75 | $267K | 26,503 |
| 2024-02-01 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −7,255 | $78.29 | $568K | 19,248 |
| 2024-02-01 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −7,255 | 21,760 |
Page 30 of 43 · 841 trades